相关实验视频

Updated: May 9, 2025

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Published on: January 20, 2023

通过免疫-PET检测电压通道1.3可视化类风湿性关节炎

Sixuan Cheng^1,2,3, Youzhuo Quan^4,5,6, Xingru Long^1,2,3

¹Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Molecular pharmaceutics

|April 29, 2025

概括

一种针对Kv1.3的新型放射性药物在风湿性关节炎 (RA) 鼠标模型中成功可视化了关节炎症. 这种标志物对早期RA诊断和监测疾病进展具有很高的敏感性.

科学领域:

免疫学免疫学免疫学
放射化学放射化学是指辐射化学.
分子成像学分子成像学

背景情况:

风湿性关节炎 (RA) 影响全球1%的人口,其特点是慢性炎症.
目前用于早期RA的诊断工具缺乏灵敏度,无法确定最佳治疗候选人.
电压通道1.3 (Kv1.3) 在驱动RA炎症的免疫细胞激活中至关重要.

研究的目的:

开发和评估一种新的Kv1.3向放射性药物,即[68Ga]Ga-NOTA-anti-Kv1.3.3.
评估它对于精确监测和量化关节炎症在RA小鼠模型中的有用性.

主要方法:

开发一种68Ga标记的Kv1.3向放射性药物.
在RA的小鼠模型中进行正子发射断层扫描 (PET) 成像.
炎症关节的组织学分析以确认目标表达.

主要成果:

PET成像显示,炎症关节的放射性度明显高于非炎症关节 (峰值吸收11.73%ID/g与1.55%ID/g).
组织学证实炎症组织中T淋巴细胞和巨细胞的高Kv1.3表达.
标记剂的摄取与临床关节炎得分有很强的相关性 (皮尔森r = 0.8789,p < 0.0001).

结论:

一种68Ga标记的Kv1.3-向放射性药物可以可视化关节炎关节的活跃炎症.
这种方法显示了对早期RA诊断和疾病监测的高度敏感性.
开发的放射性药物有可能指导免疫向治疗,并评估RA治疗的疗效.

关键词:

在PET成像中使用PET成像.免疫-PET可以使用.核医学是核医学的一种.类风湿性关节炎类风湿性关节炎电压接入通道 1.3 电压接入通道

更多相关视频

Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent

Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent

Published on: May 8, 2017

In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles

In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles

Published on: May 2, 2014

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...